The AFB Drug Susceptibility Panel (11 Drugs) evaluates Mycobacterium tuberculosis resistance patterns against a broad selection of first- and second-line anti-TB medications. Metropolis Healthcare performs this analysis on pure culture isolates, ensuring precise and clinically meaningful results. This panel supports tailored treatment planning, especially in suspected drug-resistant TB cases.
Price:
Rs. 11,075.00
Sample Type: Serum
Fasting Not Requierd
Frequently Asked Questions (FAQ's):
What does the AFB Drug Susceptibility Panel (11 Drugs) include at Metropolis Healthcare?
It tests TB bacteria against 11 key anti-tubercular drugs covering both first-line and second-line treatment options.
How does Metropolis Healthcare perform this 11-drug susceptibility test?
Pure TB cultures are analysed using standardized culture-based DST methods under strict biosafety and quality protocols.
Who should undergo this test at Metropolis Healthcare?
Patients with confirmed TB who show treatment failure, relapse, or suspected drug resistance should consider this expanded DST panel.
Why is pure culture required for this TB drug susceptibility test?
Pure culture eliminates contamination risks and ensures accurate resistance profiling without mixed-strain interference.
How do the results assist in treatment decisions?
They help physicians personalise therapy by identifying effective drugs and avoiding those to which the TB strain is resistant.
Is any special preparation needed before sending the sample?
No patient preparation is needed; the laboratory must submit a verified pure culture isolate.
How long do results take at Metropolis Healthcare?
Because the test relies on culture-based growth, results typically take several weeks.
Can this test help identify MDR and XDR TB?
Yes. The 11-drug panel offered by Metropolis Healthcare can detect multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB patterns.